Mass General Brigham Incorporated
Location
Massachusetts
Founded
1994-02-13
Risk Signals
1489 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., General Medical and Surgical Hospitals), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Mass General Brigham Incorporated
Live alerts from global media, monitored by Business Radar
2025-04-24 (sciencedaily.com)
Artificial intelligence tool helps predict relapse of pediatric brain cancer |
Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast glioma recurrence with up to 89 percent accuracy.
Read more
2025-04-23 (news-medical.net)
Electronic alerts could improve survival for patients with severe aortic stenosis
A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated.
Read more
2025-04-22 (beckershospitalreview.com)
400 Mass General Brigham physicians cleared for union vote - Becker's Hospital Review | Healthcare News & Analysis
The National Labor Relations Board has sided with primary care physicians at Mass General Brigham's Massachusetts General and Brigham and Women's hospitals by allowing the proposed 400-member bargaining unit to proceed to union election, The Boston Globe reported. The NLRB ruled April 18 that the primary care physicians belong in a single proposed bargaining unit, […]
Read more
2025-04-22 (miragenews.com)
AI Crafts Custom Enzymes for Gene Editing Breakthrough |
Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room for improvement. A new
Read more
2025-04-20 (lifeboat.com)
Scientists Develop New Gene Editing Tool that Replaces Entire Genes – News: The Blog
Scientists from Mass General Brigham and Beth Israel Deaconess Medical Center have developed a novel gene editing tool called STITCHR. Unlike traditional CRISPR, STITCHR inserts entire genes at precise locations, minimizing unintended mutations. This gene editing tool simplifies use and offers potential as a one-time treatment for genetic disorders. The technology uses retrotransposons, naturally occurring "jumping genes" found in all eukaryotic organisms, which can move and integrate into genomes. Using computational screening, the researchers identified and reprogrammed a specific retrotransposon to work with the nickase enzyme from CRISPR, forming the complete STITCHR system that allows a precise, seamless gene insertion into the genome. STITCHR offers the potential to replace or supplement entire genes, creating a more universal treatment option for various genetic diseases. The research team is now working to improve its efficiency and move it toward clinical use.
Read more
2025-04-18 (medtechspectrum.com)
Philips Healthcare Fuses AI, Analytics, and Sustainability to Redefine Anesthesia and Surgical Innovation
Philips Healthcare Fuses AI, Analytics, and Sustainability to Redefine Anesthesia and Surgical Innovation
Read more
2025-04-18 (pionline.com)
Mass General Brigham to pay $8.25 million to settle 403(b) mismanagement lawsuit | Pensions & Investments
Mass General Brigham Inc. will pay $8.25 million to settle a lawsuit alleging it mismanaged its 403(b) plan in violation of ERISA.
Read more
2025-04-18 (beckershospitalreview.com)
11 health systems reporting operating losses in 2024 - Becker's Hospital Review | Healthcare News & Analysis
Several large health systems reported operating losses in 2024, underscoring ongoing financial strain despite rising patient volumes and revenue growth. While inpatient revenue is climbing, expense pressures, cybersecurity disruptions and shifting care dynamics continue to weigh on margins — leaving even some of the nation's largest systems in the red. In February, average hospital operating […]
Read more
2025-04-17 (jdsupra.com)
Mass General Brigham study offers promise that nasal spray targeting neuroinflammation could become an effective treatment for TBI | Downs Rachlin Martin PLLC - JDSupra
The secondary cascade, although a normal physiological response, can contribute to ongoing neuroinflammation, oxidative stress and axonal injury,...
Read more